Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research
Notice Number:
NOT-DA-21-013

Key Dates

Release Date:

January 27, 2021

First Available Due Date:
March 08, 2021
Expiration Date:
December 09, 2024

Related Announcements

PA-20-248 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

PA-21-051 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

PA-20-251 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

PA-21-048 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

PA-20-142 - Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

RFA-NS-19-011 - NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)

PA-20-188 - NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

PAR-19-343 - Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)

PA-20-190 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

PA-20-203 - Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

PA-20-206 - Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)

PA-20-199 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)

PAR-19-258 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

PAR-20-236 - Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed)

PAR-19-197 - Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)

PAR-19-133 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

NOT-DA-21-061 - Notice of Change to NOT-DA-21-013, "Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research"

Issued by

National Institute on Drug Abuse (NIDA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

Data science is an important cross-cutting research approach in the NIDA Strategic Plan and increasing the capacity of experts in data science for biomedical research of addiction is critical. The purpose of this Notice is to highlight NIDA's high-priority interest in receiving applications that will support training and career development in Big Data and Computational Science (i.e., Data Science) within the overall field of addiction research. Grants supported under this Notice can be from individuals at formative career stages or from established investigators proposing training programs that will support early career scientists. Individuals from diverse backgrounds, including those from groups historically underrepresented in the STEM fields, who wish to pursue further studies or careers in Big Data and Computational Science as it relates to addiction research are highly encouraged to apply.

Examples of educational, career development, and/or research proposals in Data Science relevant to drugs of abuse and addiction training and career development include, but are not limited to:

  • Development of computational tools and artificial intelligence algorithms for secondary analysis of a variety of data types on substance use disorders, including research on the intersection of HIV/AIDS and substance use disorders.
  • Analysis of large datasets, including those relevant to the prevention and treatment of substance use disorders as well as the interactions of substance use disorders and HIV/AIDS
  • Integration of different types of large datasets
  • Development of databases relevant to addiction research, including addiction-related HIV/AIDS research
  • Development of automated computational tools to standardize data to be archived in databases

Fields of Addiction Research interest include, but are not limited to:

  • Genetics
  • Behavioral Neuroscience
  • Computational Neuroscience
  • Molecular/Cellular
  • Chemistry, including but not limited to medicinal chemistry
  • Health Disparities
  • Neuroimaging
  • Epidemiology
  • Health Services
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIAAA supports basic, translational, and clinical research on the causes, consequences, prevention, diagnosis, progression, and treatment of alcohol-related problems across the lifespan. NIAAA encourages meritorious alcohol research projects in the broad areas of neuroscience and behavior, organ damage and other health effects, epidemiology and prevention, and treatment and recovery. NIAAA also encourages meritorious research projects on alcohol-related topics of relevance to understanding and addressing minority health and health disparities and that focus on the training of a diverse research workforce.
NIAAA encourages projects that use the NIAAA Data Archive (https://www.niaaa.nih.gov/research/niaaa-data-archive) or funded initiatives with data repositories, including Collaborative Studies on Genetics of Alcoholism (COGA) study, Adolescent Brain Cognitive Development (ABCD) Study, or the Monkey Alcohol Tissue Research Resource (MATRR). More information about NIAAA’s mission and research priorities is available in the NIAAA Strategic Plan at https://www.niaaa.nih.gov/strategic-plan. For specific programmatic questions, please contact NIAAA point of contact as listed in this FOA.
Please note that for this NOSI, NIAAA will only support fellowship applications in response to the following FOAs:

Application and Submission Information

This notice applies to due dates on or after March 8, 2021 and subsequent receipt dates through December 9, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:

PA-20-248 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

PA-21-051 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

PA-20-251 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

PA-21-048 - Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

PA-20-142 - Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

PA-20-188 - NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

PAR-19-343 - Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)

PA-20-190 - Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)

PA-20-203 Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

PA-20-206 - Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)

PA-20-199 - Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)

PAR-19-258 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

PAR-20-236 - Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed)

PAR-19-197 - Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)

PAR-20-236 - Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed)

PAR-19-133 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:

  • For funding consideration, applicants must include NOT-DA-21-013 in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

For ICs not participating in the listed FOAs, check this option and fill in the text box with the name(s) of the authoring IC(s).

Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.

Inquiries

Please direct all inquiries to the contacts in Section VII of the listed funding opportunity announcements with the following additions/substitutions:

Scientific/Research Contact(s)

Susan Wright, PhD
Program Director for Big Data and Computational Science
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-6683
Email: susan.wright@nih.gov

Lindsey Friend, PhD
Office of Research Training, Diversity and Health Disparities
National Institute on Drug Abuse (NIDA)
Telephone:301-594-4673
Email: lindsey.friend@nih.gov

Elizabeth Powell, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0786
Email: elizabeth.powell3@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices